Last update 21 Nov 2024

Nocardia rubra cell wall skeleton(Benxi Shengbaokang Biotechnology Co Ltd)

Overview

Basic Info

Drug Type
Biological products
Synonyms
Nocardia rubra Cell Wall Skeleton for External Use, 红色诺卡氏菌细胞壁骨架, Na Ke Jia
+ [1]
Target-
Mechanism-
Therapeutic Areas
Urogenital DiseasesSkin and Musculoskeletal Diseases
Active Indication
Uterine Cervical ErosionSkin injury
Inactive Indication-
Originator Organization
Benxi Shengbaokang Biotechnology Co., Ltd.
Active Organization
Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (09 Feb 2003),
Uterine Cervical Erosion
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Nocardia rubra cell wall skeleton(Benxi Shengbaokang Biotechnology Co Ltd)
Login to view more data
100 Translational Medicine associated with Nocardia rubra cell wall skeleton(Benxi Shengbaokang Biotechnology Co Ltd)
Login to view more data
100 Patents (Medical) associated with Nocardia rubra cell wall skeleton(Benxi Shengbaokang Biotechnology Co Ltd)
Login to view more data
1
Literatures (Medical) associated with Nocardia rubra cell wall skeleton(Benxi Shengbaokang Biotechnology Co Ltd)
01 Aug 1982Gan
Successful regional immunotherapy with cell-wall skeletons of BCG and Nocardia rubra against autochthonous rat tumors.
100 Deals associated with Nocardia rubra cell wall skeleton(Benxi Shengbaokang Biotechnology Co Ltd)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
L03AX
-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Uterine Cervical Erosion
CN
Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.
09 Feb 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Skin injuryIND Approval
CN
Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.Shenyang Shengbaokang Biological Pharmaceutical Co., Ltd.
22 Aug 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free